Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SK-1887 single-dose phase I study in healthy adult men
jRCT2071240130Phase 1Completed
- Sponsor
- Sanwa Kagaku Kenkyusho Co., Ltd.
- Start
- Apr 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1 trial of SK-1887 (2 arms), sponsored by Sanwa Kagaku Kenkyusho Co., Ltd. Primary endpoints: Safety, Pharmacokinetics and 2 more. Started Apr 2025; status: completed.
02
Drugs
SK-1887
Beyond the preview
Go deeper on jRCT2071240130.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2071240130.